Weijing Sun
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- Peter J. O’Dwyer (26 shared papers)Daniel G. Haller (27 shared papers)Ursina Teitelbaum (8 shared papers)Robert H. Vonderheide (3 shared papers)Gregory L. Beatty (2 shared papers)Drew A. Torigian (2 shared papers)Babak Saboury (2 shared papers)E. Gabriela Chiorean (2 shared papers)
- Journals
- Journal of Clinical Oncology (49 papers)Cancer (8 papers)Clinical Cancer Research (5 papers)Journal of Hematology & Oncology (5 papers)Cancer Chemotherapy and Pharmacology (4 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Weijing Sun
196 papers receiving 8.1k citations
Weijing Sun's Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 3.9k
- Hepatology 976
- Immunology 1.6k
- Cancer Research 1.1k
- Pathology and Forensic Medicine 692
Countries citing papers authored by Weijing Sun
This map shows the geographic impact of Weijing Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijing Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijing Sun more than expected).
Fields of papers citing papers by Weijing Sun
This network shows the impact of papers produced by Weijing Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijing Sun. The network helps show where Weijing Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Weijing Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 203 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans Hit paper breakdown → | 2011 | 1339 |
| 2 | Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2019 | 504 |
| 3 | The Role of Angiogenesis in Hepatocellular Carcinoma Hit paper breakdown → | 2018 | 431 |
| 4 | 2013 | 383 | |
| 5 | 1994 | 305 | |
| 6 | 2005 | 281 | |
| 7 | 2003 | 264 | |
| 8 | 2018 | 253 | |
| 9 | Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer Hit paper breakdown → | 2020 | 236 |
| 10 | 2010 | 180 | |
| 11 | 2004 | 163 | |
| 12 | 2016 | 131 | |
| 13 | 2017 | 130 | |
| 14 | 2013 | 127 | |
| 15 | 2010 | 118 | |
| 16 | 2014 | 117 | |
| 17 | 2018 | 109 | |
| 18 | 2010 | 105 | |
| 19 | 2012 | 99 | |
| 20 | 2001 | 97 |
About Weijing Sun
Weijing Sun is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 203 papers that have together received 8.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (44 papers), Pancreatic and Hepatic Oncology Research (35 papers), Gastric Cancer Management and Outcomes (29 papers), Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cancer Immunotherapy and Biomarkers (21 papers), Cancer Treatment and Pharmacology (18 papers), Cancer Genomics and Diagnostics (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers). The work is most often cited by research in Oncology (3.9k citations), Hepatology (976 citations), Immunology (1.6k citations), Cancer Research (1.1k citations) and Pathology and Forensic Medicine (692 citations). Weijing Sun has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Peter J. O’Dwyer, Daniel G. Haller, Ursina Teitelbaum, Robert H. Vonderheide, Gregory L. Beatty, Drew A. Torigian, Babak Saboury, E. Gabriela Chiorean, Leslie L. Sharp and Wenru Song. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Clinical Cancer Research, Journal of Hematology & Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.